ICPO, a regulator of herpes simplex virus during lytic and latent infection

BioEssays

Volumn 22, Issue 8, 2000, Pages 761-770

  Everett, Roger D ^a  

^a INSTITUTE OF VIROLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMEDIATE EARLY PROTEIN; UBIQUITIN PROTEIN LIGASE; VMW110 PROTEIN, HUMAN HERPESVIRUS 1;

BIOLOGICAL MODEL; CELL CULTURE; CELL NUCLEUS; GENE EXPRESSION REGULATION; GENETICS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; PATHOGENICITY; PHYSIOLOGY; REVIEW; VIROLOGY;

CELL NUCLEUS; CELLS, CULTURED; GENE EXPRESSION REGULATION, VIRAL; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; MODELS, BIOLOGICAL; UBIQUITIN-PROTEIN LIGASES;

EID: 0033624137     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-1878(200008)22:8<761::AID-BIES10>3.0.CO;2-A     Document Type: Review

References (65)

1. rd edition Vol 2 Philadelphia: Lippincott-Raven. 1996.
2. Wagner EK, Guzowski JF, Singh J. Transcription of the herpes simplex virus genome during productive and latent infection. Prog Nucl Acids Res Mol Biol 1995 51:123-165.
3. Wagner EK, Bloom DC. Experimental investigation of herpes simplex virus latency. Crit Microbiol Rev 1997;10:419-443.
4. O'Hare P. The virion transactivator of herpes simplex virus. Sem Virol 1993;4:145-155.
5. Wilson AC, LaMarco K, Peterson MG, Herr W. The VP16 accessory protein HCF is a family of polypeptides processed from a large precursor protein. Cell 1993;74:115-125.
6. Smith CA, Bates P, Rivera-Gonzales R, Gu B, DeLuca NA. ICP4 the major transcriptional regulatory protein of herpes simplex virus type 1 forms a tri-partite complex with TATA-binding protein and TFIIB. J Virol 1993;67:4676-4687.
7. Carrozza MJ, DeLuca NA. Interaction of the viral activator protein ICP4 with TFIID through TAF250. Mol Cell Biol 1996;16:3085-3093.
8. Preston CM. Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild-type virus or the temperature sensitive mutant tsK. J Virol 1979;29:275-284.
9. DeLuca NA, McCarthy AM, Schaffer PA. Isolation and characterisation of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol 1985;56: 558-570.
10. Phelan A, Clements JB. Post-transcriptional regulation in herpes simplex virus. Sem Virol 1998;8:309-318.
11. Everett RD, Preston CM, Stow ND. Functional and genetic analysis of the role of Vmw110 in herpes simplex virus replication. In Wagner, EK. ed The control of herpes simplex virus gene expression. Boca Raton. CRC Press Inc. 1991. p50-76.
12. Everett RD. A detailed analysis of Vmw110, a trans-acting transcriptional activator encoded by herpes simplex virus type 1. EMBO J 1987;6: 2069-2076.
13. Everett RD. Analysis of the functional domains of herpes simplex virus type 1 immediate-early polypeptide Vmw110. J Mol Biol 1988;202: 87-96.
14. Fremont PS. The RING finger. A novel protein sequence related to the zinc finger. Ann NY Acad Sci 1993;684:174-192.
15. 1H-nuclear magnetic resonance spectroscopy: a new class of zinc finger. J Mol Biol 1994;237:201-211.
16. 4 motif of an alpha herpes virus protein family. J Mol Biol 1993;234:1038-1047.
17. Everett RD, Orr A, Elliott M. High level expression and purification of herpes simplex virus type 1 immediate-early polypeptide Vmw110. Nucl Acids Res 1991;19:6155-6161.
18. Stow ND, Stow EC. Isolation and characterisation of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate-early polypeptide. Vmw110 J Gen Virol 1986;67: 2571-2585.
19. Sacks WR, Schaffer PA. Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture. J Virol 1987;61:829-839.
20. Yao F, Schaffer PA. An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1. J Virol 1995;69:6249-6258.
21. Everett RD. Construction and characterisation of herpes simplex virus type 1 mutants with defined lesions in immediate-early gene 1. J Gen Virol 1989;70:1185-1202.
22. Harris RA, Everett RD, Zhu X, Silverstein S, Preston CM. The HSV immediate early protein Vmw110 reactivates latent HSV type 2 in an in vitro latency system. J Virol 1989;63:3513-3515.
23. Stow EC, Stow ND Complementation of a herpes simplex virus type 1 Vmw110 deletion mutant by human cytomegalovirus. J Gen Virol 1989; 70:695-704
24. Preston CM, Nicholl MJ. Repression of gene expression upon infection of cells with herpes simplex virus type 1 mutants impaired for immediate-early protein synthesis. J Virol 1997;71:7807-7813.
25. Samaniego LA, Neiderhiser L, DeLuca NA. Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J Virol 1998;72:3307-3320.
26. Preston CM. Repression of viral transcription during herpes simplex virus latency. J Gen Virol 2000;81:1-19.
27. Leib DA, Coen DM, Bogard CL, Hicks KA, Yager DR, Knipe DM, Tyler KL, Schaffer PA. Immediate early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J Virol 1989;63:759-768.
28. Cai W, Astor TD, Liptak LM, Cho C, Coen D, Schaffer PA. The herpes simplex virus type 1 regulatory protein ICP0 enhances replication during acute infection and reactivation from latency. J Virol 1993;67: 7501-7512.
29. Jordan R, Schaffer PA. Activation of gene expression by herpes simplex virus type 1 ICP0 occurs at the level of mRNA synthesis. J Virol 1997; 71:6850-6862.
30. Maul GG, Guldner HH, Spivack JG. Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate-early gene 1 product ICP0. J Gen Virol 1993;74:2679-2690.
31. 4 viral protein ICP0 J Gen Virol 1994;75:1223-1233.
32. Everett RD, Maul GG. HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J 1994;13:5062-5069.
33. Sternsdorf T, Grotzinger T, Jensen K, Will H. Nuclear dots: Actors on many stages. Immunobiology 1997;198:307-331.
34. Maul GG. DNA virus transcription and replicalion at a specific nuclear domain ND10. Bioessays 1998;20:660-667.
35. Sternsdorf T, Jensen K, Will H. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J Cell Biol 1997;139:1621-1634.
36. Muller S, Matunis MJ, Dejean A. Conjugation of the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J 1998;17:61-70.
37. Kamitani T, Kito K, Nguyen HP, Wada H, Fukuda-Kamitani T, Yeh ETH. Identification of three major sentrinization sites in PML. J Biol Chem 1998;273:26675-26682.
38. Duprez E, Saurin AJ. Desterro JM, Lallemand-Breitenbach V, Howe K, Boddy MN. Soloman E, de The H, Hay RT, Freemont PS. SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear organisation. J Cell Sci 1999;112:381-393.
39. Everett RD, Lomonte P, Sternsdorf T, van Driel R, Orr A. Cell cycle regulation of PML modification and ND10 composition. 1999;112: 4581-4588.
40. Maul GG Yu E, Ishov AM, Epstein AL. Nuclear domain 10 ND10 associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress. J Cell Biochem 1995;59: 498-513.
41. Meredith MR, Orr A, Elliott M, Everett RD. Separation of the sequence requirements for HSV-1 Vmw110 multimerisation and interaction with a 135KD cellular protein. Virology 1995;209:174-187.
42. Maul GG, Ishov A, Everett RD. Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type 1. Virology 1996;217:67-75.
43. Ishov AM, Maul GG. The periphery of nuclear domain 10 ND10 as site of DNA virus deposition. J Cell Biol 1996;134:815-826.
44. Everett RD, Meredith MR, Orr A Cross A, Kathoria M, Parkinson J. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and b nds to a herpesvirus regulatory protein. EMBO J 1997;16:1519-1530.
45. Wilkinson KD. Roles of ubiquitination in proteolysis and cellular regulation Ann Rev Nutr 1995;15:161-189.
46. Everett RD, Meredith MR, Orr A. The ability of herpes simplex virus type 1 immediate-early protein Vmw110 to bind to a ubiquitin-specific protease contributes to its roles in the activation of gene expression and stimulation of virus infection. J Virol 1999;73: 417-426.
47. Everett RD, Freemont P, Saitoh H, Dasso M, Orr A, Kathoria M, Parkinson J The d sruption of ND10 during herpes simplex virus infection correlates with the Vmw110 and proteasome-dependent loss of several PML isoforms J Virol 1998;72:6581-6591.
48. Muller S, Dejean A. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins correlating with nuclear body disruption. J Virol 1999;73:5137-5143.
49. Chelbi-Alix MK, de The H. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene 1999;18:935-941.
50. Everett RD, Earnshaw WC, Findlay J, Lomonte P. Specific destruction of kinetochore protein CENP-C and disruption of cell division by herpes simplex virus immediate-early protein Vmw110. EMBO J 1999;18: 1526-1538.
51. Parkinson J, Lees-Miller SP, Everett RD. Herpes simplex virus immediate early protein Vmw110 induces the proteasome-dependent degradation of DNA-PKcs. J Virol 1999;73:650-657.
52. Everett RD, Orr A, Preston CM. A viral activator of gene expression functions via the ubiquitin-proteasome pathway. EMBO J 1998;17: 7161-7169.
53. Lehming N, Le Saux A, Schuller J, Ptashne M. Chromatin components as par: of a putative transcriptional repressing complex. Proc Natl Acad Sci USA 1998;95:7322-7326.
54. Seeler JS, Marchio A, Sitterlin D, Transby C, Dejean A. Interaction of sp100 with HP1 proteins: A link between the promyelocytic leukaemia-associated nuclear bodies and the chromatin compartment. Proc Natl Acad Sci USA 1998;95:7316-7321.
55. Everett RD, Earnshaw WC, Pluta AF. Sternsdorf T, Ainsztein AM, Carmena M, Ruchaud S, Hsu W-L, Orr A. A dynamic connection between centromeres and ND10 proteins. 1999;112:3443-3454.
56. Elgin SCR. Heterochromatin and gene regulation in Drosophila. Curr Op Genet Dev 1996;6:193-202.
57. Eissenberg JC, James TC, Foster-Hartnett DM, Harnett T, Ngan V, Elgin SCR. Mutation in a heterochromatin-specific chromosomal protein is associated with suppression of position-effect variegation in Drosophila melanogaster. Proc Natl Acad Sci USA 1990;87:9923-9927.
58. Eissenberg JC, Morris G, Reuter G, Harnett T. The heterochromatin associated protein HP1 is an essential protein in Drosophila with dosage effects on position effect variegation. Genetics 1992;131: 345-352.
59. Cockell M, Gasser SM. Nuclear compartments and gene regulation. Curr Opin Genet Dev 1999;9:199-205.
60. Yao F, Schaffer PA. Physical interaction between the herpes simplex virus type 1 immediate-early regulatory proteins ICP0 and ICP4. J Virol 1994;68:8158-8168.
61. Kawaguchi Y, Brunei R, Roizman B. Interaction of herpes simplex virus 1 α regulatory protein ICP0 with elongation factor 1Δ: ICP0 affects translational machinery. J Virol 1997;71:1019-1024.
62. Van Sant C, Kawaguchi Y, Roizman B. A single amino acid substitution in the cyclin D binding domain of the infected cell protein no. 0 abrogates the neuroinvasiveness of herpes simplex virus without affecting its ability to replicate. Proc Natl Acad Sci USA 1999;96 8184-8189.
63. Maniatis T, Aubiquitin ligase complex essential for the FK-αB, Wnt/Wingless and Hedgehog signalling pathways Genes Dev 1999;13:505-510.
64. Freemont PS. Ubiquitination: RING for destruction? Curr Biol 2000;10: R84-R87.
65. Kristie TM, Vogel JL, Sears AE. Nuclear localisation of the C1 factor (host cell factor) in sensory neurons correlates with reactivation of herpes simplex virus from latency. Proc Natl Acad Sci USA 1999;96:1229-1233.